 | • レポートコード：MRC2-11QY11210 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は水疱性類天疱瘡治療のグローバル市場について調査・分析したレポートです。種類別（免疫抑制薬、ステロイド、抗生物質・防腐剤、鎮痛薬）市場規模、用途別（病院薬局、小売薬局、通信販売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別水疱性類天疱瘡治療の競争状況、市場シェア ・世界の水疱性類天疱瘡治療市場：種類別市場規模 2015年-2020年（免疫抑制薬、ステロイド、抗生物質・防腐剤、鎮痛薬） ・世界の水疱性類天疱瘡治療市場：種類別市場規模予測 2021年-2026年（免疫抑制薬、ステロイド、抗生物質・防腐剤、鎮痛薬） ・世界の水疱性類天疱瘡治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、通信販売薬局） ・世界の水疱性類天疱瘡治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、通信販売薬局） ・北米の水疱性類天疱瘡治療市場分析：米国、カナダ ・ヨーロッパの水疱性類天疱瘡治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの水疱性類天疱瘡治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の水疱性類天疱瘡治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの水疱性類天疱瘡治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Aqua Pharmaceuticals、Sirius Laboratories、DUBLIN Pharmaceuticals、Teva Pharmaceuticals、Astellas Pharma、Aegis Pharmaceuticals、Sun Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bullous pemphigoid is a chronic, inflammatory skin disease that involves the formation of blisters. The bullous may be of different forms such as generalized, vesicular, vegetative, Urticarial, Nodular, Acral or infant forms. The disease is not gender biased and can also occur in younger adults but is rare in infants. The blood blister due to bullous pemphigoid occur in people aging above 70 years. Bullous pemphigoid occurs when the immune system outbreaks a thin layer of tissue below the outer layer of skin. It is more prevalent in patients suffering from dermatitis and neurological disease, predominantly in stroke and dementia. The bullous pemphigoid blister develops on the skin area that tend to flex such as lower abdomen, upper thigh and armpits. Bullous Pemphigoid causes severe itch, tense bullae, annular lesions, post inflammatory pigmentation, blood stained blister fluids and urticaria-like red skin. Proper medication involved in overturning the immune system plays an important role in treatment of the disease.
Rising geriatric population over the globe increase chances of occurrence of disease and thus the surge in treatment options. Common and non-expensive medication uses in the treatment of disease increases fuels the treatment market. Furthermore, various awareness programs by healthcare organizations and NGOs supports the proliferation of treatment market. Non-availability of healthcare facilities in various less developed regions of globe with high incidence rate of disease restricts the overall market to grow.
Market Analysis and Insights: Global Bullous Pemphigoid Treatment Market
The global Bullous Pemphigoid Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bullous Pemphigoid Treatment Scope and Market Size
Bullous Pemphigoid Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bullous Pemphigoid Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Aqua Pharmaceuticals
Sirius Laboratories
DUBLIN Pharmaceuticals
Teva Pharmaceuticals
Astellas Pharma
Aegis Pharmaceuticals
Sun Pharmaceuticals
Market segment by Type, the product can be split into
Immunosuppressant Medication
Steroids
Antibiotics & Antiseptics
Pain Relief Medication
Market segment by Application, split into
Hospitals Pharmacies
Retail Pharmacies
Mail Order Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bullous Pemphigoid Treatment Revenue
1.4 Market by Type
1.4.1 Global Bullous Pemphigoid Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunosuppressant Medication
1.4.3 Steroids
1.4.4 Antibiotics & Antiseptics
1.4.5 Pain Relief Medication
1.5 Market by Application
1.5.1 Global Bullous Pemphigoid Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Mail Order Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bullous Pemphigoid Treatment Market Perspective (2015-2026)
2.2 Global Bullous Pemphigoid Treatment Growth Trends by Regions
2.2.1 Bullous Pemphigoid Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bullous Pemphigoid Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Bullous Pemphigoid Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bullous Pemphigoid Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Bullous Pemphigoid Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bullous Pemphigoid Treatment Players by Market Size
3.1.1 Global Top Bullous Pemphigoid Treatment Players by Revenue (2015-2020)
3.1.2 Global Bullous Pemphigoid Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Bullous Pemphigoid Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bullous Pemphigoid Treatment Market Concentration Ratio
3.2.1 Global Bullous Pemphigoid Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bullous Pemphigoid Treatment Revenue in 2019
3.3 Bullous Pemphigoid Treatment Key Players Head office and Area Served
3.4 Key Players Bullous Pemphigoid Treatment Product Solution and Service
3.5 Date of Enter into Bullous Pemphigoid Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bullous Pemphigoid Treatment Historic Market Size by Type (2015-2020)
4.2 Global Bullous Pemphigoid Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Bullous Pemphigoid Treatment Market Size by Application (2015-2020)
5.2 Global Bullous Pemphigoid Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bullous Pemphigoid Treatment Market Size (2015-2020)
6.2 Bullous Pemphigoid Treatment Key Players in North America (2019-2020)
6.3 North America Bullous Pemphigoid Treatment Market Size by Type (2015-2020)
6.4 North America Bullous Pemphigoid Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Bullous Pemphigoid Treatment Market Size (2015-2020)
7.2 Bullous Pemphigoid Treatment Key Players in Europe (2019-2020)
7.3 Europe Bullous Pemphigoid Treatment Market Size by Type (2015-2020)
7.4 Europe Bullous Pemphigoid Treatment Market Size by Application (2015-2020)
8 China
8.1 China Bullous Pemphigoid Treatment Market Size (2015-2020)
8.2 Bullous Pemphigoid Treatment Key Players in China (2019-2020)
8.3 China Bullous Pemphigoid Treatment Market Size by Type (2015-2020)
8.4 China Bullous Pemphigoid Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Bullous Pemphigoid Treatment Market Size (2015-2020)
9.2 Bullous Pemphigoid Treatment Key Players in Japan (2019-2020)
9.3 Japan Bullous Pemphigoid Treatment Market Size by Type (2015-2020)
9.4 Japan Bullous Pemphigoid Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bullous Pemphigoid Treatment Market Size (2015-2020)
10.2 Bullous Pemphigoid Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bullous Pemphigoid Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Bullous Pemphigoid Treatment Market Size by Application (2015-2020)
11 India
11.1 India Bullous Pemphigoid Treatment Market Size (2015-2020)
11.2 Bullous Pemphigoid Treatment Key Players in India (2019-2020)
11.3 India Bullous Pemphigoid Treatment Market Size by Type (2015-2020)
11.4 India Bullous Pemphigoid Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bullous Pemphigoid Treatment Market Size (2015-2020)
12.2 Bullous Pemphigoid Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Bullous Pemphigoid Treatment Market Size by Type (2015-2020)
12.4 Central & South America Bullous Pemphigoid Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Bullous Pemphigoid Treatment Introduction
13.1.4 Pfizer Revenue in Bullous Pemphigoid Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Aqua Pharmaceuticals
13.2.1 Aqua Pharmaceuticals Company Details
13.2.2 Aqua Pharmaceuticals Business Overview
13.2.3 Aqua Pharmaceuticals Bullous Pemphigoid Treatment Introduction
13.2.4 Aqua Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2015-2020)
13.2.5 Aqua Pharmaceuticals Recent Development
13.3 Sirius Laboratories
13.3.1 Sirius Laboratories Company Details
13.3.2 Sirius Laboratories Business Overview
13.3.3 Sirius Laboratories Bullous Pemphigoid Treatment Introduction
13.3.4 Sirius Laboratories Revenue in Bullous Pemphigoid Treatment Business (2015-2020)
13.3.5 Sirius Laboratories Recent Development
13.4 DUBLIN Pharmaceuticals
13.4.1 DUBLIN Pharmaceuticals Company Details
13.4.2 DUBLIN Pharmaceuticals Business Overview
13.4.3 DUBLIN Pharmaceuticals Bullous Pemphigoid Treatment Introduction
13.4.4 DUBLIN Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2015-2020)
13.4.5 DUBLIN Pharmaceuticals Recent Development
13.5 Teva Pharmaceuticals
13.5.1 Teva Pharmaceuticals Company Details
13.5.2 Teva Pharmaceuticals Business Overview
13.5.3 Teva Pharmaceuticals Bullous Pemphigoid Treatment Introduction
13.5.4 Teva Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2015-2020)
13.5.5 Teva Pharmaceuticals Recent Development
13.6 Astellas Pharma
13.6.1 Astellas Pharma Company Details
13.6.2 Astellas Pharma Business Overview
13.6.3 Astellas Pharma Bullous Pemphigoid Treatment Introduction
13.6.4 Astellas Pharma Revenue in Bullous Pemphigoid Treatment Business (2015-2020)
13.6.5 Astellas Pharma Recent Development
13.7 Aegis Pharmaceuticals
13.7.1 Aegis Pharmaceuticals Company Details
13.7.2 Aegis Pharmaceuticals Business Overview
13.7.3 Aegis Pharmaceuticals Bullous Pemphigoid Treatment Introduction
13.7.4 Aegis Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2015-2020)
13.7.5 Aegis Pharmaceuticals Recent Development
13.8 Sun Pharmaceuticals
13.8.1 Sun Pharmaceuticals Company Details
13.8.2 Sun Pharmaceuticals Business Overview
13.8.3 Sun Pharmaceuticals Bullous Pemphigoid Treatment Introduction
13.8.4 Sun Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2015-2020)
13.8.5 Sun Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Bullous Pemphigoid Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Bullous Pemphigoid Treatment Revenue
Table 3. Ranking of Global Top Bullous Pemphigoid Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bullous Pemphigoid Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunosuppressant Medication
Table 6. Key Players of Steroids
Table 7. Key Players of Antibiotics & Antiseptics
Table 8. Key Players of Pain Relief Medication
Table 9. Global Bullous Pemphigoid Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Bullous Pemphigoid Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Bullous Pemphigoid Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Bullous Pemphigoid Treatment Market Share by Regions (2015-2020)
Table 13. Global Bullous Pemphigoid Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Bullous Pemphigoid Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Bullous Pemphigoid Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Bullous Pemphigoid Treatment Players
Table 20. Global Bullous Pemphigoid Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Bullous Pemphigoid Treatment Market Share by Players (2015-2020)
Table 22. Global Top Bullous Pemphigoid Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bullous Pemphigoid Treatment as of 2019)
Table 23. Global Bullous Pemphigoid Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Bullous Pemphigoid Treatment Product Solution and Service
Table 26. Date of Enter into Bullous Pemphigoid Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Bullous Pemphigoid Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Bullous Pemphigoid Treatment Market Size Share by Type (2015-2020)
Table 30. Global Bullous Pemphigoid Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Bullous Pemphigoid Treatment Market Size Share by Application (2015-2020)
Table 32. Global Bullous Pemphigoid Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Bullous Pemphigoid Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Bullous Pemphigoid Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Bullous Pemphigoid Treatment Market Share (2019-2020)
Table 36. North America Bullous Pemphigoid Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Bullous Pemphigoid Treatment Market Share by Type (2015-2020)
Table 38. North America Bullous Pemphigoid Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Bullous Pemphigoid Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Bullous Pemphigoid Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Bullous Pemphigoid Treatment Market Share (2019-2020)
Table 42. Europe Bullous Pemphigoid Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Bullous Pemphigoid Treatment Market Share by Type (2015-2020)
Table 44. Europe Bullous Pemphigoid Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Bullous Pemphigoid Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Bullous Pemphigoid Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Bullous Pemphigoid Treatment Market Share (2019-2020)
Table 48. China Bullous Pemphigoid Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Bullous Pemphigoid Treatment Market Share by Type (2015-2020)
Table 50. China Bullous Pemphigoid Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Bullous Pemphigoid Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Bullous Pemphigoid Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Bullous Pemphigoid Treatment Market Share (2019-2020)
Table 54. Japan Bullous Pemphigoid Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Bullous Pemphigoid Treatment Market Share by Type (2015-2020)
Table 56. Japan Bullous Pemphigoid Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Bullous Pemphigoid Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Bullous Pemphigoid Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Bullous Pemphigoid Treatment Market Share (2019-2020)
Table 60. Southeast Asia Bullous Pemphigoid Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Bullous Pemphigoid Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Bullous Pemphigoid Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Bullous Pemphigoid Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Bullous Pemphigoid Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Bullous Pemphigoid Treatment Market Share (2019-2020)
Table 66. India Bullous Pemphigoid Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Bullous Pemphigoid Treatment Market Share by Type (2015-2020)
Table 68. India Bullous Pemphigoid Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Bullous Pemphigoid Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Bullous Pemphigoid Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Bullous Pemphigoid Treatment Market Share (2019-2020)
Table 72. Central & South America Bullous Pemphigoid Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Bullous Pemphigoid Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Bullous Pemphigoid Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Bullous Pemphigoid Treatment Market Share by Application (2015-2020)
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Product
Table 79. Pfizer Revenue in Bullous Pemphigoid Treatment Business (2015-2020) (Million US$)
Table 80. Pfizer Recent Development
Table 81. Aqua Pharmaceuticals Company Details
Table 82. Aqua Pharmaceuticals Business Overview
Table 83. Aqua Pharmaceuticals Product
Table 84. Aqua Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2015-2020) (Million US$)
Table 85. Aqua Pharmaceuticals Recent Development
Table 86. Sirius Laboratories Company Details
Table 87. Sirius Laboratories Business Overview
Table 88. Sirius Laboratories Product
Table 89. Sirius Laboratories Revenue in Bullous Pemphigoid Treatment Business (2015-2020) (Million US$)
Table 90. Sirius Laboratories Recent Development
Table 91. DUBLIN Pharmaceuticals Company Details
Table 92. DUBLIN Pharmaceuticals Business Overview
Table 93. DUBLIN Pharmaceuticals Product
Table 94. DUBLIN Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2015-2020) (Million US$)
Table 95. DUBLIN Pharmaceuticals Recent Development
Table 96. Teva Pharmaceuticals Company Details
Table 97. Teva Pharmaceuticals Business Overview
Table 98. Teva Pharmaceuticals Product
Table 99. Teva Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2015-2020) (Million US$)
Table 100. Teva Pharmaceuticals Recent Development
Table 101. Astellas Pharma Company Details
Table 102. Astellas Pharma Business Overview
Table 103. Astellas Pharma Product
Table 104. Astellas Pharma Revenue in Bullous Pemphigoid Treatment Business (2015-2020) (Million US$)
Table 105. Astellas Pharma Recent Development
Table 106. Aegis Pharmaceuticals Company Details
Table 107. Aegis Pharmaceuticals Business Overview
Table 108. Aegis Pharmaceuticals Product
Table 109. Aegis Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2015-2020) (Million US$)
Table 110. Aegis Pharmaceuticals Recent Development
Table 111. Sun Pharmaceuticals Business Overview
Table 112. Sun Pharmaceuticals Product
Table 113. Sun Pharmaceuticals Company Details
Table 114. Sun Pharmaceuticals Revenue in Bullous Pemphigoid Treatment Business (2015-2020) (Million US$)
Table 115. Sun Pharmaceuticals Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bullous Pemphigoid Treatment Market Share by Type: 2020 VS 2026
Figure 2. Immunosuppressant Medication Features
Figure 3. Steroids Features
Figure 4. Antibiotics & Antiseptics Features
Figure 5. Pain Relief Medication Features
Figure 6. Global Bullous Pemphigoid Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Mail Order Pharmacies Case Studies
Figure 10. Bullous Pemphigoid Treatment Report Years Considered
Figure 11. Global Bullous Pemphigoid Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Bullous Pemphigoid Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Bullous Pemphigoid Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Bullous Pemphigoid Treatment Market Share by Players in 2019
Figure 16. Global Top Bullous Pemphigoid Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bullous Pemphigoid Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Bullous Pemphigoid Treatment Revenue in 2019
Figure 18. North America Bullous Pemphigoid Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Bullous Pemphigoid Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Bullous Pemphigoid Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Bullous Pemphigoid Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Bullous Pemphigoid Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Bullous Pemphigoid Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Bullous Pemphigoid Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
慢性腰痛治療の世界市場（～2026年） Low back pain can be standardized into two categories, acute and chronic. Pain for less than three months can be classified as acute, while continued pain for more than three months is classified as chronic. Market Analysis and Insights: Global Chronic Low Back Pain Treatment Market The global Chron…- 逆流性腎症治療の世界市場（～2026年） Reflux nephropathy is kidney damage (nephropathy) due to urine flowing backward (reflux) from the bladder toward the kidneys. The symptoms of reflux nephropathy are comparable to nephrotic syndrome and infection of the urinary tract, though some individuals may not exhibit any evidence (symptom) of …
- リウマチ熱治療の世界市場（～2026年） Rheumatic fever is an autoimmune inflammatory disease which can develop as a complication of inadequately treated strep throat. Strep throat is a condition caused by group a Streptococcus bacterium. Rheumatic fever is common in the age group of 5 to 15 years, but adults can also have the condition. …
- 自己管理薬の世界市場（～2026年） Self-administration is, in its medical sense, the process of a subject administering a pharmacological substance to themself. A clinical example of this is the subcutaneous "self-injection" of insulin by a diabetic patient. By distribution channel, the hospital pharmacies segment is expected to repr…
- 眼炎症治療の世界市場（～2026年） Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the …